224 related articles for article (PubMed ID: 24347166)
1. Crucial positively charged residues for ligand activation of the GPR35 receptor.
Zhao P; Lane TR; Gao HG; Hurst DP; Kotsikorou E; Le L; Brailoiu E; Reggio PH; Abood ME
J Biol Chem; 2014 Feb; 289(6):3625-38. PubMed ID: 24347166
[TBL] [Abstract][Full Text] [Related]
2. Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα₁₃ and β-arrestin-2.
Jenkins L; Alvarez-Curto E; Campbell K; de Munnik S; Canals M; Schlyer S; Milligan G
Br J Pharmacol; 2011 Feb; 162(3):733-48. PubMed ID: 20958291
[TBL] [Abstract][Full Text] [Related]
3. Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35.
Taniguchi Y; Tonai-Kachi H; Shinjo K
FEBS Lett; 2006 Sep; 580(21):5003-8. PubMed ID: 16934253
[TBL] [Abstract][Full Text] [Related]
4. G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast.
Cosi C; Mannaioni G; Cozzi A; Carlà V; Sili M; Cavone L; Maratea D; Moroni F
Neuropharmacology; 2011 Jun; 60(7-8):1227-31. PubMed ID: 21110987
[TBL] [Abstract][Full Text] [Related]
5. G protein-coupled receptor 35 contributes to mucosal repair in mice via migration of colonic epithelial cells.
Tsukahara T; Hamouda N; Utsumi D; Matsumoto K; Amagase K; Kato S
Pharmacol Res; 2017 Sep; 123():27-39. PubMed ID: 28648739
[TBL] [Abstract][Full Text] [Related]
6. Targeting of the orphan receptor GPR35 by pamoic acid: a potent activator of extracellular signal-regulated kinase and β-arrestin2 with antinociceptive activity.
Zhao P; Sharir H; Kapur A; Cowan A; Geller EB; Adler MW; Seltzman HH; Reggio PH; Heynen-Genel S; Sauer M; Chung TD; Bai Y; Chen W; Caron MG; Barak LS; Abood ME
Mol Pharmacol; 2010 Oct; 78(4):560-8. PubMed ID: 20826425
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13.
Jenkins L; Brea J; Smith NJ; Hudson BD; Reilly G; Bryant NJ; Castro M; Loza MI; Milligan G
Biochem J; 2010 Dec; 432(3):451-9. PubMed ID: 20919992
[TBL] [Abstract][Full Text] [Related]
8. G protein-coupled estrogen receptor 1 (GPER1)/GPR30 increases ERK1/2 activity through PDZ motif-dependent and -independent mechanisms.
Gonzalez de Valdivia E; Broselid S; Kahn R; Olde B; Leeb-Lundberg LMF
J Biol Chem; 2017 Jun; 292(24):9932-9943. PubMed ID: 28450397
[TBL] [Abstract][Full Text] [Related]
9. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
10. Ligand directed signaling differences between rodent and human κ-opioid receptors.
Schattauer SS; Miyatake M; Shankar H; Zietz C; Levin JR; Liu-Chen LY; Gurevich VV; Rieder MJ; Chavkin C
J Biol Chem; 2012 Dec; 287(50):41595-607. PubMed ID: 23086943
[TBL] [Abstract][Full Text] [Related]
11. Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) has a critical role in GLP-1 peptide binding and receptor activation.
Koole C; Wootten D; Simms J; Miller LJ; Christopoulos A; Sexton PM
J Biol Chem; 2012 Feb; 287(6):3642-58. PubMed ID: 22147710
[TBL] [Abstract][Full Text] [Related]
12. Kynurenic acid and zaprinast induce analgesia by modulating HCN channels through GPR35 activation.
Resta F; Masi A; Sili M; Laurino A; Moroni F; Mannaioni G
Neuropharmacology; 2016 Sep; 108():136-43. PubMed ID: 27131920
[TBL] [Abstract][Full Text] [Related]
13. Second extracellular loop of human glucagon-like peptide-1 receptor (GLP-1R) differentially regulates orthosteric but not allosteric agonist binding and function.
Koole C; Wootten D; Simms J; Savage EE; Miller LJ; Christopoulos A; Sexton PM
J Biol Chem; 2012 Feb; 287(6):3659-73. PubMed ID: 22147709
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II type 1 receptor variants alter endosomal receptor-β-arrestin complex stability and MAPK activation.
Cao Y; Kumar S; Namkung Y; Gagnon L; Cho A; Laporte SA
J Biol Chem; 2020 Sep; 295(38):13169-13180. PubMed ID: 32703898
[TBL] [Abstract][Full Text] [Related]
15. G-Protein-Coupled Receptor 35 Mediates Human Saphenous Vein Vascular Smooth Muscle Cell Migration and Endothelial Cell Proliferation.
McCallum JE; Mackenzie AE; Divorty N; Clarke C; Delles C; Milligan G; Nicklin SA
J Vasc Res; 2015; 52(6):383-95. PubMed ID: 27064272
[TBL] [Abstract][Full Text] [Related]
16. Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation.
Xu TR; Ward RJ; Pediani JD; Milligan G
J Biol Chem; 2012 Apr; 287(18):14937-49. PubMed ID: 22389503
[TBL] [Abstract][Full Text] [Related]
17. GPR35 is a novel lysophosphatidic acid receptor.
Oka S; Ota R; Shima M; Yamashita A; Sugiura T
Biochem Biophys Res Commun; 2010 Apr; 395(2):232-7. PubMed ID: 20361937
[TBL] [Abstract][Full Text] [Related]
18. The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35.
MacKenzie AE; Caltabiano G; Kent TC; Jenkins L; McCallum JE; Hudson BD; Nicklin SA; Fawcett L; Markwick R; Charlton SJ; Milligan G
Mol Pharmacol; 2014 Jan; 85(1):91-104. PubMed ID: 24113750
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of N-type calcium channels by activation of GPR35, an orphan receptor, heterologously expressed in rat sympathetic neurons.
Guo J; Williams DJ; Puhl HL; Ikeda SR
J Pharmacol Exp Ther; 2008 Jan; 324(1):342-51. PubMed ID: 17940199
[TBL] [Abstract][Full Text] [Related]
20. Isoforms of GPR35 have distinct extracellular N-termini that allosterically modify receptor-transducer coupling and mediate intracellular pathway bias.
Schihada H; Klompstra TM; Humphrys LJ; Cervenka I; Dadvar S; Kolb P; Ruas JL; Schulte G
J Biol Chem; 2022 Sep; 298(9):102328. PubMed ID: 35933013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
